Tight control using fecal calprotectin and early disease intervention increase the rates of transmural remission in Crohn's disease.

United European Gastroenterol J · 2024 · PMC11091787 · PMID 38093503

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a decreasing trendno p-value reported

Cases with a decreasing trend of fecal calprotectin were still considered positive if ≥ 250 μg/g.

also in 47,180 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.